In recent trading, shares of Genmab A/S (Symbol: GMAB) have crossed above the average analyst 12-month target price of $43.85, changing hands for $44.69/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.